Cargando…
Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
OBJECTIVES: The aim of this study was to investigate 3 Tesla multiparametric magnetic resonance imaging (mpMRI)-based predictors for the pretherapeutic T staging of prostate cancer and their accuracy. METHODS: Consecutive patients with 3 Tesla mpMRI, positive systematic and MR-targeted biopsy, and s...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205913/ https://www.ncbi.nlm.nih.gov/pubmed/33452898 http://dx.doi.org/10.1007/s00261-020-02913-9 |
_version_ | 1783708559067840512 |
---|---|
author | Valentin, B. Schimmöller, L. Ullrich, T. Klingebiel, M. Demetrescu, D. Sawicki, L. M. Lakes, J. Mally, D. Quentin, M. Esposito, I. Albers, P. Antoch, G. Arsov, C. |
author_facet | Valentin, B. Schimmöller, L. Ullrich, T. Klingebiel, M. Demetrescu, D. Sawicki, L. M. Lakes, J. Mally, D. Quentin, M. Esposito, I. Albers, P. Antoch, G. Arsov, C. |
author_sort | Valentin, B. |
collection | PubMed |
description | OBJECTIVES: The aim of this study was to investigate 3 Tesla multiparametric magnetic resonance imaging (mpMRI)-based predictors for the pretherapeutic T staging of prostate cancer and their accuracy. METHODS: Consecutive patients with 3 Tesla mpMRI, positive systematic and MR-targeted biopsy, and subsequent radical prostatectomy (RPE) between 01/2016 and 12/2017 were included. MRI parameters such as measurable extraprostatic extension (EPE) (≥ 3 mm), length of (pseudo)capsular contact (LCC), invasion of neurovascular bundle (NVBI), and/or seminal vesicles lesion contact (SVC) or infiltration (SVI) were assessed and correlated to clinical and histopathological results. RESULTS: 136 men were included. In 76 cases, a pT2 stage was determined, in 29 cases a pT3a, and in 31 a pT3b stage. The positive and negative predictive values (PPV, NPV) for the detection of T3 by measurable EPE on MRI was 98% (CI 0.88–1) and 81% (CI 0.72–0.87). No visible NVBI was found in pT2 patients (NPV 100%; CI 0.95–1). ROC analysis for T3a prediction with LCC (AUC 0.81) showed a sensitivity of 87% and a specificity of 62% at a threshold of 12.5 mm (J = 0.485) and 93% and 58% at 11 mm (J(max) = 0.512). All patients with pT3a had a LCC > 5 mm. In case of pT3b, 29/31 patients showed a SVC (PPV 76%, CI 0.61–0.87; NPV 98%, CI 0.93–0.99), and 23/31 patients showed a SVI (PPV 100%, CI 0.86–1; NPV 93%, CI 0.87–0.96). EPE (p < 0.01), LCC (p = 0.05), and SVC (p = 0.01) were independent predictors of pT3. CONCLUSIONS: MRI-measurable EPE, LCC, and SVC were reliable, independent, preoperative predictors for a histopathological T3 stage. A LCC ≥ 11 mm indicated a pT3a stage, whereas a LCC < 5 mm excluded it. On MRI, visible SVI or even SVC of the PCa lesion was reliable preoperative predictors for a pT3b stage. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00261-020-02913-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8205913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-82059132021-07-01 Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer Valentin, B. Schimmöller, L. Ullrich, T. Klingebiel, M. Demetrescu, D. Sawicki, L. M. Lakes, J. Mally, D. Quentin, M. Esposito, I. Albers, P. Antoch, G. Arsov, C. Abdom Radiol (NY) Pelvis OBJECTIVES: The aim of this study was to investigate 3 Tesla multiparametric magnetic resonance imaging (mpMRI)-based predictors for the pretherapeutic T staging of prostate cancer and their accuracy. METHODS: Consecutive patients with 3 Tesla mpMRI, positive systematic and MR-targeted biopsy, and subsequent radical prostatectomy (RPE) between 01/2016 and 12/2017 were included. MRI parameters such as measurable extraprostatic extension (EPE) (≥ 3 mm), length of (pseudo)capsular contact (LCC), invasion of neurovascular bundle (NVBI), and/or seminal vesicles lesion contact (SVC) or infiltration (SVI) were assessed and correlated to clinical and histopathological results. RESULTS: 136 men were included. In 76 cases, a pT2 stage was determined, in 29 cases a pT3a, and in 31 a pT3b stage. The positive and negative predictive values (PPV, NPV) for the detection of T3 by measurable EPE on MRI was 98% (CI 0.88–1) and 81% (CI 0.72–0.87). No visible NVBI was found in pT2 patients (NPV 100%; CI 0.95–1). ROC analysis for T3a prediction with LCC (AUC 0.81) showed a sensitivity of 87% and a specificity of 62% at a threshold of 12.5 mm (J = 0.485) and 93% and 58% at 11 mm (J(max) = 0.512). All patients with pT3a had a LCC > 5 mm. In case of pT3b, 29/31 patients showed a SVC (PPV 76%, CI 0.61–0.87; NPV 98%, CI 0.93–0.99), and 23/31 patients showed a SVI (PPV 100%, CI 0.86–1; NPV 93%, CI 0.87–0.96). EPE (p < 0.01), LCC (p = 0.05), and SVC (p = 0.01) were independent predictors of pT3. CONCLUSIONS: MRI-measurable EPE, LCC, and SVC were reliable, independent, preoperative predictors for a histopathological T3 stage. A LCC ≥ 11 mm indicated a pT3a stage, whereas a LCC < 5 mm excluded it. On MRI, visible SVI or even SVC of the PCa lesion was reliable preoperative predictors for a pT3b stage. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00261-020-02913-9) contains supplementary material, which is available to authorized users. Springer US 2021-01-16 2021 /pmc/articles/PMC8205913/ /pubmed/33452898 http://dx.doi.org/10.1007/s00261-020-02913-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Pelvis Valentin, B. Schimmöller, L. Ullrich, T. Klingebiel, M. Demetrescu, D. Sawicki, L. M. Lakes, J. Mally, D. Quentin, M. Esposito, I. Albers, P. Antoch, G. Arsov, C. Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer |
title | Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer |
title_full | Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer |
title_fullStr | Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer |
title_full_unstemmed | Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer |
title_short | Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer |
title_sort | magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer |
topic | Pelvis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205913/ https://www.ncbi.nlm.nih.gov/pubmed/33452898 http://dx.doi.org/10.1007/s00261-020-02913-9 |
work_keys_str_mv | AT valentinb magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT schimmollerl magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT ullricht magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT klingebielm magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT demetrescud magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT sawickilm magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT lakesj magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT mallyd magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT quentinm magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT espositoi magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT albersp magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT antochg magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer AT arsovc magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer |